Akari Therapeutics, Plc (AKTX) Earnings Call Transcripts

8 earnings calls from August 2020 to June 4, 2026

NasdaqCM US Health Care Biotechnology

About Akari Therapeutics, Plc

Akari Therapeutics, Plc (AKTX) is a publicly listed company in the Biotechnology industry, within the Health Care sector. It trades on NasdaqCM and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 8 calls on record spanning August 31, 2020 to June 4, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 8 Akari Therapeutics, Plc earnings call transcripts on record, spanning August 31, 2020 to June 4, 2026. Based on this history, Akari Therapeutics, Plc reports annually. The most recent call on file is dated June 4, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
AKTX
Exchange
NasdaqCM
Country
US
Sector
Health Care
Industry
Biotechnology
Calls on record
8
First call
August 31, 2020
Most recent
June 4, 2026
Reporting cadence
annually
Quarter Date
Special Calls Jun 4, 2026 Read transcript
Special Calls Feb 11, 2026 Read transcript
Shareholder/Analyst Calls Nov 18, 2025 Read transcript
Company Conference Presentations Sep 8, 2025 Read transcript
Special Calls Sep 4, 2025 Read transcript
Special Calls Jun 25, 2025 Read transcript
Special Calls May 22, 2023 Read transcript
Special Calls Aug 31, 2020 Read transcript